Evidence map›Paper›PMID 33208780›Full record

ArticleScientific reports2020

JavaCyte, a novel open-source tool for automated quantification of key hallmarks of cardiac structural remodeling.

J Winters, M Edler von Braunmuhl, S Zeemering, M Gilbers, T Ten Brink, B Scaf, E Guasch, L Mont, M Batlle, M Sinner and 9 more

Abstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Histological evaluation of clinically defined atrial cardiomyopathy stages and their association with atrial fibrillation burden under continuous monitoring for a 2.5-year follow-up.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Right atrial endomysial fibrosis is associated with increased postoperative atrial fibrillation burden during 2.5 years of continuous rhythm monitoring after cardiac surgery including atrial arrhythmia surgery: RACE V Tissue Bank Study.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Familial atrial fibrillation mutation M1875T-SCN5A increases early sodium current and dampens the effect of flecainide.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Article
  14. Endomysial fibrosis, rather than overall connective tissue content, is the main determinant of conduction disturbances in human atrial fibrillation.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2022
    Article
  15. Review
  16. Increased fibroblast accumulation in the equine heart following persistent atrial fibrillation.International journal of cardiology. Heart & vasculature · 2021
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

J WintersDepartment of Physiology, Cardiovascular Research Institute Maastricht, Universiteitssingel 50, P.O. Box 616, 6200 MD, Maastricht, The Netherlands.
M Edler von BraunmuhlDepartment of Physiology, Cardiovascular Research Institute Maastricht, Universiteitssingel 50, P.O. Box 616, 6200 MD, Maastricht, The Netherlands.
S ZeemeringDepartment of Physiology, Cardiovascular Research Institute Maastricht, Universiteitssingel 50, P.O. Box 616, 6200 MD, Maastricht, The Netherlands.
M GilbersDepartment of Physiology, Cardiovascular Research Institute Maastricht, Universiteitssingel 50, P.O. Box 616, 6200 MD, Maastricht, The Netherlands.
T Ten BrinkDepartment of Physiology, Cardiovascular Research Institute Maastricht, Universiteitssingel 50, P.O. Box 616, 6200 MD, Maastricht, The Netherlands.
B ScafDepartment of Physiology, Cardiovascular Research Institute Maastricht, Universiteitssingel 50, P.O. Box 616, 6200 MD, Maastricht, The Netherlands.
E GuaschCardiovascular Institute, Hospital Clinic de Barcelona, Barcelona, Spain.
L MontCardiovascular Institute, Hospital Clinic de Barcelona, Barcelona, Spain.
M BatlleCardiovascular Institute, Hospital Clinic de Barcelona, Barcelona, Spain.
M SinnerUniversity Heart and Vascular Center, UKE Hamburg, Hamburg, Germany.
S HatemINSERM UMRS1166, ICAN - Institute of CardioMetabolism and Nutrition, Sorbonne Université, Institut de Cardiologie, Hôpital Pitié-Salpêtrière, Paris, France.
M K MansourHôpital Necker Enfants Malades, Paris, France.
L FabritzInstitute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK.
L C SommerfeldInstitute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK.
P KirchhofInstitute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK.
A IsaacsDepartment of Physiology, Cardiovascular Research Institute Maastricht, Universiteitssingel 50, P.O. Box 616, 6200 MD, Maastricht, The Netherlands.
M StollDepartment of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht, The Netherlands.
U SchottenDepartment of Physiology, Cardiovascular Research Institute Maastricht, Universiteitssingel 50, P.O. Box 616, 6200 MD, Maastricht, The Netherlands.
S VerheuleDepartment of Physiology, Cardiovascular Research Institute Maastricht, Universiteitssingel 50, P.O. Box 616, 6200 MD, Maastricht, The Netherlands. s.verheule@maastrichtuniversity.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many cardiac pathologies involve changes in tissue structure. Conventional analysis of structural features is extremely time-consuming and subject to observer bias. The possibility to determine spatial interrelations between these features is often not fully exploited. We developed a staining protocol and an ImageJ-based tool (JavaCyte) for automated histological analysis of cardiac structure, including quantification of cardiomyocyte size, overall and endomysial fibrosis, spatial patterns of endomysial fibrosis, fibroblast density, capillary density and capillary size. This automated analysis was compared to manual quantification in several well-characterized goat models of atrial fibrillation (AF). In addition, we tested inter-observer variability in atrial biopsies from the CATCH-ME consortium atrial tissue bank, with patients stratified by their cardiovascular risk profile for structural remodeling. We were able to reproduce previous manually derived histological findings in goat models for AF and AV block (AVB) using JavaCyte. Furthermore, strong correlation was found between manual and automated observations for myocyte count (r = 0.94, p < 0.001), myocyte diameter (r = 0.97, p < 0.001), endomysial fibrosis (r = 0.98, p < 0.001) and capillary count (r = 0.95, p < 0.001) in human biopsies. No significant variation between observers was observed (ICC = 0.89, p < 0.001). We developed and validated an open-source tool for high-throughput, automated histological analysis of cardiac tissue properties. JavaCyte was as accurate as manual measurements, with less inter-observer variability and faster throughput.

Indexed as

AlgorithmsAutomationAgedAnimalsAtrial FibrillationFemaleGoatsHeart AtriaHumansMaleMiddle Aged

Identifiers

PMID33208780
PMCPMC7675975

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.